Back to results
US 2021/0171945 A1Published application
Methods of modulating antisense activity
AssigneeIonis Pharmaceuticals, Inc.
InventorsXue-hai Liang, Stanley T. Crooke
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for increasing antisense activity by modulating translation. In certain embodiments, a compound comprising an antisense oligonucleotide is co-administered with an inhibitor of translation.
Claims48
A method comprising
- contacting a cell with an antisense compound comprising an antisense oligonucleotide, wherein the nucleobase sequence of the antisense oligonucleotide is complementary to a target mRNA and
- contacting the cell with an inhibitor of translation.
Use of an antisense oligonucleotide with a nucleobase sequence complementary to the coding region of a target mRNA in combination with an inhibitor of translation for treatment of a disease.
Dependencies are inferred from the claim text.